Protalix Biotherapeutics Inc. (PLX)
NYSE · Healthcare
Protalix Biotherapeutics Inc. Gross Profit 2009–2025
Protalix Biotherapeutics Inc. annual/quarterly gross profit history and growth rate from 2009 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Protalix Biotherapeutics Inc. gross profit for the quarter ending March 31, 2026 was 29.6 M, a 1432.49% increase year-over-year.
- Protalix Biotherapeutics Inc. gross profit for the twelve months ending March 31, 2026 was 50.9 M, a 151.84% increase year-over-year.
- Protalix Biotherapeutics Inc. annual gross profit for 2025 was 25.8 M, a 11.45% decrease from 2024.
- Protalix Biotherapeutics Inc. annual gross profit for 2024 was 29.1 M, a 31.60% decrease from 2023.
- Protalix Biotherapeutics Inc. annual gross profit for 2023 was 42.5 M, a 51.58% increase from 2022.
- Protalix Biotherapeutics Inc. annual gross profit for 2022 was 28.0 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Protalix Biotherapeutics Inc. Gross Profit — FAQ
Protalix Biotherapeutics Inc. (PLX) gross profit over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Protalix Biotherapeutics Inc.'s gross profit?
Protalix Biotherapeutics Inc. (PLX) reported gross profit of $26M for fiscal 2025.
Where can I see PLX's gross profit history?
The chart and table above show Protalix Biotherapeutics Inc.'s gross profit by year and by quarter, including the growth rate.